Fenthion

Fenthion

SCHEMBL6739014

COP(=S)(OC)Oc1ccc(SC)c(C)c1.COP(=S)(OC)Oc1ccc(SC)c(C)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 1.00
CYP3A4 P08684 4/20 1.00
TSHR P16473 2/20 1.00
HSD17B10 Q99714 2/20 1.00
HPGD P15428 3/20 0.47
LMNA P02545 2/20 0.41
THRB P10828 2/20 0.41
TP53 P04637 1/20 0.41
MAPK1 P28482 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
STS P08842 3/20 0.37
SLC6A4 P31645 3/20 0.37
TAS1R3 Q7RTX0 2/20 0.33
TAS1R1 Q7RTX1 2/20 0.33
TDP1 Q9NUW8 2/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
GUSB P08236 1/20 0.31
KDM4E B2RXH2 1/20 0.31
CA12 O43570 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fenthion SCHEMBL26907 1.00 ALDH1A1 (1.00) ALDH1A1CYP3A4TSHRHSD17B10HPGD
Fenthion SCHEMBL29441335 1.00 ALDH1A1 (1.00) ALDH1A1CYP3A4TSHRHSD17B10HPGD
Fenthion SCHEMBL28673475 0.97 ALDH1A1 (0.94) ALDH1A1CYP3A4TSHRHSD17B10HPGD
Fenthion SCHEMBL1933208 0.90 ALDH1A1 (0.81) ALDH1A1CYP3A4TSHRHSD17B10HPGD
SCHEMBL120468 0.83 ALDH1A1 (0.70) ALDH1A1CYP3A4TSHRHSD17B10HPGD
SCHEMBL3621986 0.81 ALDH1A1 (0.69) ALDH1A1CYP3A4TSHRHSD17B10HPGD
SCHEMBL12799246 0.80 ALDH1A1 (0.67) ALDH1A1CYP3A4TSHRHSD17B10HPGD
SCHEMBL30494373 0.80 CYP3A4 (0.67) ALDH1A1CYP3A4TSHRHSD17B10HPGD
SCHEMBL5933982 0.80 CYP3A4 (0.67) ALDH1A1CYP3A4TSHRHSD17B10HPGD
Fenthion SCHEMBL11808276 0.80 ALDH1A1 (0.64) ALDH1A1CYP3A4TSHRHSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6680065-B2 FOR TREATMENT OF WOODY PLANTS; EMPLOYED IN HOLLOW PREFORMED IN THE WOODY PLANT BAYER AKTIENGESELLSCHAFT (DE) 2004-01-20 US disclosed
US-20010039248-A1 Shaped bodies which release agrochemical active substances PODSZUN WOLFGANG (DE) 2001-11-08 US disclosed
EP-0564945-B1 A method of controlling harmful insects BAYER AGROCHEM KK (JP) 2001-01-24 EP disclosed
US-6063393-A RODS OR PINS TO BE PRESSED INTO PLANTS NIHON BAYER AGROCHEM K.K. (JP) 2000-05-16 US disclosed
US-5925676-A INSECICIDES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1999-07-20 US disclosed
EP-0564945-A1 A method of controlling harmful insects NIHON BAYER AGROCHEM K.K. (JP) 1993-10-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010039248-A1 Shaped bodies which release agrochemical active substances AGL, CHMP4B, GUSB ALDH1A1 758/4885CYP3A4 686/4885TSHR 4602/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.